Butirosin is a new aminoglycosidic antibiotic complex which has broad gramnegative and gram-positive inhibitory antibacterial activity, as well as some bactericidal properties. Significantly susceptible bacteria include strains of Staphylococcus aureus and Streptococcus pyogenes, and pathogenic gram-negative species such as Enterobacter aerogenes, Escherichia coli, Klebsiella pnewnoniae, Proteus mirabilis and P. vulgaris, Salmonella enteritidis and S. typhimuriwn, Shigellaflexneri and S. sonnei. Good activity by parenteral dosing was obtained in various acute mouse infections. Butirosin is especially interesting because of its activity against Pseudomonas aeruginosa in vitro, including gentamicin-resistant clinical isolates, and in experimental mouse infections at relatively low doses.
The discovery and production of butirosin, a new aminoglycosidic antibiotic complex, has been reported by Howells et al. (3) and Dion et al. (1) . A description of its chemical and physical characteristics was presented by Woo et al. (7) (8) (9) . In this communication, data are given on the in vitro and mouse-protective antibacterial activities of this new antibiotic.
MATERIALS AND METHODS The antibiotics were handled, evaluated, and reported on the basis of total weight rather than base content. The most frequently used antibiotics (all sulfates) were: butirosin, 710 ,g of base/mg; colistin, 630 Ag of base/mg; gentamicin, 554 Ag of base/mg; kanamycin, 785 ,g of base/mg; nebramycin complex; neomycin, 660,ug of base/mg; paromomycin, 700 jg of base/mg; polymyxin B, 7,200 units/mg; and streptomycin, 750 ,g of base/mg. Butirosin is a complex (3) containing ca. 80 to 85% component A and 15 to 20% component B.
Minimal inhibitory concentrations (MIC) were determined generally according to the methods described by Fisher et al. (2) . Inocula of approximately 1,000 cells in 0.1 ml of medium were added to tubes containing twofold decremental dilutions of antibiotic in 5-ml volumes of Trypticase soy broth (TSB) or synthetic TB medium. The inoculated tubes were incubated for 18 to 24 hr (14 days for Mycobacterium tuberculosis) at 37 C before observation.
To determine bactericidal effects, decremental tube dilutions in 5 ml of broth were inoculated with approximately 106 cells per tube. After overnight incubation at 37 C, a loopful of medium from each inoculated clear tube was streaked onto a Trypticase soy agar plate. After 24 hr of incubation at 37 C, these suculture plates were observed for the presence and relative numbers of surviving bacteria. The lowest concentration of butirosin producing a distinct, marked reduction in numbers as revealed by such subculture was regarded as the minimal bactericidal concentration.
The influence of serum and inoculum size on bacteriostatic activity was determined by the method used for initial MIC determinations. However, light (103 cells) and heavy (106 cells) inocula were compared. The test media included not only TSB, but also TSB fortified with 10% bovine serum or 50% pooled human serum.
Increases in resistance for a given strain were attempted by the transfer of heavy inocula through rising concentrations of antibiotic (butirosin, gentamicin, and colistin) in TSB. Three to 10 transfers were required before the MIC values of these strains were increased to 5 100 Mg/ml. By use of light inocula, the MIC values of several antibiotics were compared against the resistant variants of a Klebsiella pneumoniae and a Staphylococcus aureus, and their sensitive parent strains. In another series, butirosin, gentamicin, and colistin, as well as streptomycin, kanamycin, and paromomycin, were compared for their activity against bacteria with increased resistance to the first three of these drugs. As before, the sensitive parent cultures were included.
Clinically obtained antibiotic-resistant isolates were subjected to the same broth dilution ( Table 2 . Butirosin usually exhibited bactericidal activity at concentrations equal to or double the MIC.
Results of tests involving serum and inoculum size effects are summarized in Table 3 . Subjected to a 1,000-fold increase in inoculum, butirosin MIC values were usually elevated four-to eightfold. The presence of 10% bovine serum or 50% human serum had no significant effect on activity.
In vitro antibacterial comparisons were made between butirosin and some structurally similar antibiotics. The results (Table 4) demonstrate that butirosin possesses the spectrum characteristic of gentamicin (5) and nebramycin (6) and is active at similar concentrations.
Butirosin-resistant progeny of S. aureus and K. pneumoniae strains, obtained by in vitro selection, were compared with their parent cultures for susceptibility to various other antibiotics ( Table 5 ). The butirosin-resistant derivative strains were also resistant to all the other aminoglycosidic antibiotics tested: gentamicin, neomycin, kanamycin, paromomycin, and streptomycin. No changes in susceptibility were encountered with the unrelated compounds: novo- 
